CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor
2020 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-020-03037-0
G
Guoliang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
1.8K
Citations
24
h-index
53
i10-index
Guoliang Zhang is an academic researcher from Qingdao University. The author has contributed to research in topics: Proteoglycans and glycosaminoglycans research & Cancer Cells and Metastasis & Cancer-related molecular mechanisms research. The author has an h-index of 24, co-authored 90 publications.
ORCID: 0009-0004-2768-4120Papers by this author
worksComprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
2023 · Cell Discovery · 28 citations
https://doi.org/10.1038/s41421-023-00614-3
CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
2020 · Cancer Cell International · 22 citations
https://doi.org/10.1186/s12935-020-01663-4
Schizophyllum commune fruiting body polysaccharides inhibit glioma by mediating ARHI regulation of PI3K/AKT signalling pathway
2024 · International Journal of Biological Macromolecules · 13 citations
https://doi.org/10.1016/j.ijbiomac.2024.135326
Activation of CD44 signaling in leader cells induced by tumor-associated macrophages drives collective detachment in luminal breast carcinomas
2022 · Cell Death and Disease · 12 citations
https://doi.org/10.1038/s41419-022-04986-4
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
2022 · Journal of Experimental & Clinical Cancer Research · 9 citations
https://doi.org/10.1186/s13046-022-02463-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat